HomeCompareSHKBF vs PFE

SHKBF vs PFE: Dividend Comparison 2026

SHKBF yields 4.57% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $29.1K in total portfolio value· pulled ahead in Year 9
10 years
SHKBF
SHKBF
● Live price
4.57%
Share price
$19.34
Annual div
$0.88
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.5K
Annual income
$0.46
Full SHKBF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — SHKBF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSHKBFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SHKBF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SHKBF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHKBF
Annual income on $10K today (after 15% tax)
$388.38/yr
After 10yr DRIP, annual income (after tax)
$0.39/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,319.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHKBF + PFE for your $10,000?

SHKBF: 50%PFE: 50%
100% PFE50/50100% SHKBF
Portfolio after 10yr
$35.0K
Annual income
$13,129.59/yr
Blended yield
37.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

SHKBF
No analyst data
Altman Z
3.4
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHKBF buys
0
PFE buys
0
No recent congressional trades found for SHKBF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSHKBFPFE
Forward yield4.57%6.13%
Annual dividend / share$0.88$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%13.2%
Portfolio after 10y$20.5K$49.6K
Annual income after 10y$0.46$26,258.71
Total dividends collected$463.00$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SHKBF vs PFE ($10,000, DRIP)

YearSHKBF PortfolioSHKBF Income/yrPFE PortfolioPFE Income/yrGap
1$10,928$228.46$9,153$693.39+$1.8KSHKBF
2$11,810$116.67$8,593$849.25+$3.2KSHKBF
3$12,696$58.92$8,336$1,066.78+$4.4KSHKBF
4$13,614$29.60$8,437$1,384.80+$5.2KSHKBF
5$14,582$14.83$9,013$1,875.40+$5.6KSHKBF
6$15,610$7.42$10,306$2,680.72+$5.3KSHKBF
7$16,706$3.71$12,820$4,101.38+$3.9KSHKBF
8$17,878$1.86$17,673$6,826.70+$205.00SHKBF
9← crossover$19,130$0.93$27,543$12,591.86$8.4KPFE
10$20,470$0.46$49,560$26,258.71$29.1KPFE

SHKBF vs PFE: Complete Analysis 2026

SHKBFStock

Shibuya Corporation manufactures and sells packaging and mechatronics systems in Japan and internationally. The company offers bottling systems for SAKE and distilled spirit bottling system, liquor bottling system, beer bottling system, dairy product bottling system, seasoning bottling system, cooking oil bottling system, cosmetics bottling system, personal care products bottling system, chemical product bottling system, health and nutritional drink bottling system, and mineral water bottling system; and packaging systems, such as caser/uncaser, wrap-around caser, cartoning, case former, case sealing, multi packer, cup filling/sealing, cup and tray sealing, pouch filling and sealing, gusset packaging, corrugate sheet providing, container folding assembly, polyethylene film applicator, poly bag sealing, and packaging system machines. It also provides pharmaceutical manufacturing systems, including isolator systems, sterilization/decontamination systems, filling systems, validation, preparation facilities, and various pharmaceutical manufacturing systems; regenerative medicine manufacturing systems; super heated steam cooking system and ultra-high pressure processing system; and production management systems. In addition, the company provides fiber laser cutting machines; CO2 laser cutting machines; YAG laser welding machines, laser ablation machines, laser/water cutting machines, water jet cutting machines, other cutting machines, and hydraulic presses; solder ball mounter, bonders for optical communication and optical devices, flip chip bonders/high-accuracy die bonders, high-accuracy bonders for image sensors, wire bonder, LED inspection/sorting/taping machines, 3D vision inspection systems, and battery manufacturing systems; medical equipment systems; cleaning / environmental equipment systems; and agricultural equipment systems. Shibuya Corporation was founded in 1931 and is headquartered in Kanazawa, Japan.

Full SHKBF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this SHKBF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHKBF vs SCHDSHKBF vs JEPISHKBF vs OSHKBF vs KOSHKBF vs MAINSHKBF vs JNJSHKBF vs MRKSHKBF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.